Skip to search formSkip to main contentSkip to account menu

sebelipase alfa

Known as: SBC-102 
National Institutes of Health

Related topics

Related topics

5 relations
10 ML sebelipase alfa 2 MG/ML Injection [Kanuma]Lysosomal Acid Cholesterol Esteraseanalogs & derivatives

Narrower (1)

Kanuma

Broader (1)

sterol esterase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Veränderung der Leberfibrose bei Kindern und Erwachsenen mit lysosomalem saure Lipase Mangel (LAL-D) nach 52-wöchiger Therapie mit Sebelipase alfa (SebA) (ARISE Studie)
2017
2017
Langzeitnutzen der Enzymersatztherapie (EET) mit Sebelipase alfa (SebA) über 76 Wochen bei Kindern und Erwachsenen mit lysosomaler saurer Lipase Defizienz (LAL-D) (ARISE)
2013
2013
Approach to management of cross-reactive immunologic material (CRIM)-negative infantile pompe patients treated with ERT: Role of immune modulation in changing the natural history
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)